Бурсагова Бэлла Ибрагимовна
Ministry of Health of the Russian Federation · 70 works · 105 citations · h-index 4
Top works
- The First Russian Consensus on the Multilevel Abobotulinumtoxin A Injections in Spastic Forms of Cerebral Palsy
- Drooling in Patients with Cerebral Palsy: The Effectiveness of Botulinum Toxin A Treatment
- EХPERIENCE IN INTERFERON β-1A USE FOR TREATMENT OF MULTIPLE SCLEROSIS IN CHILDREN
- Multilevel Botulinum Toxin A (Abobotulinum Toxin A) Injections in Spastic Forms of Cerebral Palsy: Retrospective Analysis of 8 Russian Centers Experience
- Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy
- IncobotulinumtoxinA in the treatment of sialorrhea in patients with infantile cerebral palsy
- Quality of life in patients with cerebral palsy: literature review
- Features of parameters of cellular immune depending on the activity of foci of demyelination in children with multiple sclerosis
- Multilevel botulinum toxin treatment in severe spastic forms of cerebral palsy (GMFCS IV—V)
- Differential diagnosis of Duchenne muscular dystrophy
- Normative parameters of motor nerve conduction studies in infants
- EXPERIENCE OF THE TYPE A BOTULINUM TOXIN TYPE (ONABOTULINUMTOXINA) DRUG IN TREATMENT OF CEREBRAL PALSY PATIENTS
- THERAPEUTIC METHODS IN CEREBRAL PALSY FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE
- Use of botulinum toxin type A (Botox) in the treatment of infantile cerebral palsy
- A clinical case of severe Duchenne muscular dystrophy caused by a nonsense mutation in the DMD gene in a girl
- Selection of a dose of the botulinum toxin A in spastic forms of cerebral palsy
- The efficacy of gene therapy with onasemnogene abeparvovec in spinal muscular atrophy in young patients
- Changes in cytokine complexes in children with autoimmune diseases with different effectiveness of their biological therapy
- Changes of the spasticity patterns in children with cerebral palsy GMFCS III at the age of 2 to 12 years
- Sialorrhea in children with mucopolysaccharidosis type II (a review of several clinical cases)